Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Prostatic Neoplasms, Castration-Resistant × Abiraterone Acetate × Clear all

Phase

Status

Active not recruiting 3 Withdrawn 2 Unknown 2 Completed 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 16 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer Metastatic 1 NSCLC Harboring NRG1 Fusion 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Adenocarcinoma 1

Interventions

enzalutamide 3 abiraterone 2 tasquinimod 1 sabizabulin 1 darolutamide 1 Nivolumab 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04844749 2024-02-05

VERACITY

Veru Inc.

Phase 3 Terminated

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡